Internal Medicine, Hematology & Oncology · Garland, TX
NPI
1033226006
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
315 N Shiloh Rd, Suite 101
Garland, TX, 75042
Phone (972) 487-8866
Groups this clinician bills Medicare through
Medicare paid, 2024
$868K
52,962 services
Medicare patients, 2024
317
Average age 75
Drug cost, 2024
$2.6M
1,312 prescriptions
Company payments, 2025
$2,384
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zhiyong Li was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 9,080 times for 26 patients. In total Zhiyong Li billed 52,962 services in 70 codes, and Medicare paid $868K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 9,080 | 26 | $6.43 | $58K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,570 | 40 | $0.09 | $232 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,260 | 18 | $0.70 | $881 |
| 99214 Office E&M - Established | Office | 1,035 | 175 | $92.84 | $96K |
| 96367 Intravenous Infusion, Hydration | Office | 993 | 42 | $20.98 | $21K |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 714 | 44 | $1.04 | $739 |
| 99233 Hospital E&M - Subsequent | Facility | 638 | 124 | $86.70 | $55K |
| 36415 Venipuncture Blood Collection | Office | 556 | 132 | $8.65 | $4,809 |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 504 | 11 | $41.26 | $21K |
| J1750 Injection, iron dextran, 50 mg | Office | 390 | 21 | $13.76 | $5,368 |
| 99291 Critical Care E&M | Facility | 335 | 44 | $155.43 | $52K |
| 96372 Injection Administration | Office | 307 | 41 | $10.56 | $3,241 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 280 | 42 | $0.65 | $181 |
| J3490 Unclassified drugs | Office | 279 | 42 | $0.56 | $155 |
| 96413 Chemotherapy Administration | Office | 218 | 21 | $95.69 | $21K |
By year: 2022 $1.6M for 78,636 services; 2023 $1.3M for 59,888 services; 2024 $868K for 52,962 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 556 | 132 | $8.65 | $4,809 |
Medicare prescription drug claims, 2024
In 2024, the drug Zhiyong Li prescribed most often to Medicare patients was Eliquis (Apixaban), with 93 prescriptions and refills. In total Zhiyong Li wrote 1,312 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 93 | 103 | 19 | $56K |
| Warfarin Sodium Generic | 74 | 174 | 21 | $785 |
| Anastrozole Generic | 71 | 197 | 22 | $1,654 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 52 | 52 | Under 11 | $2,108 |
| Hydroxyurea Generic | 51 | 101 | 14 | $1,102 |
| Gabapentin Generic | 48 | 82 | 18 | $996 |
| Alprazolam Generic | 48 | 48 | Under 11 | $710 |
| Amlodipine Besylate Generic | 39 | 113 | 13 | $546 |
| Dexamethasone Generic | 35 | 37 | 11 | $492 |
| Ondansetron Hcl Generic | 33 | 33 | 11 | $309 |
| Morphine Sulfate Generic | 28 | 28 | Under 11 | $1,353 |
| Imatinib Mesylate Generic | 26 | 26 | Under 11 | $1,915 |
| Lenalidomide Generic | 26 | 26 | Under 11 | $468K |
| Zolpidem Tartrate Generic | 26 | 28 | Under 11 | $217 |
| Xtandi Enzalutamide | 24 | 28 | Under 11 | $391K |
Brand drugs: - claims; generic drugs: 1,034 claims; opioid claims: 123.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zhiyong Li $2,384 ($2,384 in general payments such as food, travel and fees) from 33 companies. The largest payer was Janssen Biotech, Inc. with $374.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 14 | $374 |
| GlaxoSmithKline, LLC. GSK | 10 | $216 |
| Sobi, Inc SOBI.ST | 4 | $175 |
| Array Biopharma Inc PFE | 9 | $144 |
| Merck Sharp & Dohme LLC MRK | 6 | $126 |
| Pfizer Inc. PFE | 5 | $116 |
| Syndax Pharmaceuticals, Inc. SNDX | 4 | $109 |
| Exelixis Inc. EXEL | 4 | $105 |
| Karyopharm Therapeutics Inc. KPTI | 4 | $93.34 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $86.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.